Novo Nordisk A/SNVONYSE
Loading
Pre-tax income as a percentage of revenue
3Y CAGR
+2.7%/yr
vs -2.2%/yr prior
5Y CAGR
+0.2%/yr
Consistent
Acceleration
+4.8pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 42.24% | -3.6% |
| 2024 | 43.80% | -2.8% |
| 2023 | 45.07% | +15.5% |
| 2022 | 39.03% | -7.0% |
| 2021 | 41.96% | +0.3% |
| 2020 | 41.85% | +5.2% |
| 2019 | 39.79% | -6.5% |
| 2018 | 42.58% | -2.3% |
| 2017 | 43.58% | +1.9% |
| 2016 | 42.76% | - |